Budecort (Budesonide Inhaler) is used for the maintenance treatment of asthma as prophylactic therapy in adult and pediatric patients.

1. Budesonide Inhaler
© Clearsky Pharmacy
Budecort (Budesonide Inhaler) is used for
the maintenance treatment of asthma as
prophylactic therapy in adult and pediatric
patients.

2. Budecort Inhaler
© Clearsky Pharmacy
Budecort Inhaler is manufactured by
Cipla Ltd., India
(Website: www.cipla.com)

3. Budesonide Inhalers – Brand Names
© Clearsky Pharmacy
Budesonide Inhaler is available as
Pulmicort, Budecort, Bubate, Budez
Inhaler, Airtec-FB ,Combihale-FB and
Derinide.

4. Active Ingredient
© Clearsky Pharmacy
The active ingredient contained in Budecort
Inhaler is Budesonide.
Each actuation delivers 100 mcg
(BUDECORT 100 Inhaler) or 200 mcg of
Budesonide (BUDECORT 200 Inhaler).

5. Chemical Structure
© Clearsky Pharmacy
The structure of Budesonide is given below:

6. Uses of Budesonide Inhaler
© Clearsky Pharmacy
Budecort Inhaler is used in the long-term
management of asthma and chronic
obstructive pulmonary disease (COPD).
Budecort (Budesonide Inhaler) is indicated
for the maintenance treatment of asthma as
prophylactic therapy in adult and pediatric
patients. It is also indicated for patients
requiring oral corticosteroid therapy for
asthma. Many of those patients may be able
to reduce or eliminate their requirement for
oral corticosteroids over time.
Budecort Inhaler is not indicated for the
relief of acute bronchospasm.

7. Storage Instructions
© Clearsky Pharmacy
Budecort (Budesonide Inhaler) has to
be stored at controlled room temperature
i.e. from 20°C to 25°C (68°F to 77°F) in
a dry place with the cover tightly in
place.
Keep this as well as all other medicines
away from children and pets.

8. Warnings
© Clearsky Pharmacy
Patients Not Dependent on Steroids:
Treatment with the recommended doses
of Budesonide inhaler usually gives a
therapeutic benefit within 10 days.
However patients with an excessive
collection of mucous secretion in the
bronchi have to be given a short course
of oral corticosteroids (usually 1-2
weeks) in addition to the aerosol.

9. Warnings
© Clearsky Pharmacy
Steroid-Dependent Patients:
Transfer of patients on oral steroids to
treatment with budesonide inhaler requires
special care, mainly due to the slow
restitution of the disturbed hypothalamic-
pituitary-adrenal (HPA) axis function,
caused by extended treatment with oral
corticosteroids. When the Budesonide
inhaler treatment is started, the patient
should be in a relatively stable phase.
Budesonide inhaler is then administered in
combination with the previously used oral
steroid dose for about 10 days.

10. Warnings
© Clearsky Pharmacy
Budecort (Budesonide Inhaler) is not
intended for rapid relief of acute
episodes of asthma or symptoms of
asthma. In such cases an inhaled
short-acting bronchodilator is required.
Patients must be advised to have such
'rescue' medication with them at all
times.

11. Budesonide Inhaler Dosage
© Clearsky Pharmacy
➢200 mcg to 1,600 mcg daily, in divided doses.
200 micrograms twice daily, in the morning and in
the evening. During periods of severe asthma the
daily dosage can be increased up to 1600
micrograms.
➢In patients whose asthma is well controlled, the
daily dose can be reduced below 400 micrograms
but should not go below 200 micrograms.
➢Patients must be maintained on the lowest dose
that will effectively control symptoms.
The dosage of Budecort Inhaler (Budesonide
Inhaler) for adults including the elderly and
Children Over 12 Years is given below:

12. Budesonide Inhaler Dosage
© Clearsky Pharmacy
➢200 mcg to 800 mcg daily, in divided doses. The dose
must be reduced to the minimum needed to maintain
good asthma control.
➢The patient has to be transferred to once daily dosing
at the same equivalent total daily dose; the drug and
method of delivery should be considered. The dose
should subsequently be reduced to the minimum
required to maintain good asthma control.
The dosage of Budecort (Budesonide Inhaler) for
children between 2 years to 12 years of age is
given below:

13. Budecort Inhaler
© Clearsky Pharmacy
Contraindications
Budecort Inhaler is contraindicated in
patients with a hypersensitivity to
Budesonide or any other component of
this medication.
Budecort Inhaler is contraindicated in the
primary treatment of status asthmaticus or
other acute episodes of asthma where
intensive measures are necessary.

14. Budesonide Inhaler Side Effects
© Clearsky Pharmacy
➢Budecort (Budesonide Inhaler) side effects can
include mild irritation in the throat, Candida infection
in the oropharynx, hoarseness, coughing,
nasopharyngitis, nasal congestion, pharyngitis,
allergic rhinitis, viral upper respiratory tract infection,
nausea, viral gastroenteritis, otitis media, oral
candidiasis, respiratory infection, sinusitis,
headache, pain, back pain, fever, neck pain,
syncope, abdominal pain, dry mouth, vomiting,
weight gain, fracture, myalgia, hypertonia, migraine,
ecchymosis, insomnia, infection, taste perversion,
voice alteration, asthenia, dyspepsia, arthralgia,
increased cough and rhinitis

15. Overdose
© Clearsky Pharmacy
The only harmful effect that follows
inhalation of large amounts of this medicine
over a short period is suppression of the
HPA axis function.
No special emergency action is required to
be taken.
Treatment with Budecort Inhaler should be
continued at the recommended dose to
control the asthma.

16. Budesonide During Pregnancy
© Clearsky Pharmacy
Budesonide (Budecort Inhaler) has been
classified by the US FDA as Pregnancy Category
B.
During controlled animal studies,
glucocorticosteroids have been shown to induce
malformations.
This is not likely to be relevant for humans given
recommended doses, but therapy with inhaled
Budesonide must be regularly reviewed and
maintained at the lowest effective dose.
Budecort Inhaler must only be used during
pregnancy if the expected benefits outweigh the
potential risks.

17. Budecort Inhaler
For more details on
Budecort Inhaler click here
© Clearsky Pharmacy
Budecort (Budesonide Inhaler) by
Cipla Limited, India .